Paul A Mahon, EVP & General Counsel at UNITED THERAPEUTICS, sold UTHR on Jul 16, 2026
Data as of Oct 16
- Traded
- Jul 16, 2026
- Disclosed
- Jul 16, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
UTHR since disclosure
+0.8%
after the sale
Similar stocks (XLV) since disclosure
+9.2%
XLV — its sector index fund
Change in closing price from Jul 16, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLPaul A Mahon EVP & General CounselUTHR UNITED THERAPEUTICS Corp$1.8Mdisclosed Jul 16 · filed the same day
- ▼ SELLPaul A Mahon EVP & General CounselUTHR UNITED THERAPEUTICS Corp$426Kdisclosed Jul 16 · filed the same day
- ▼ SELLPaul A Mahon EVP & General CounselUTHR UNITED THERAPEUTICS Corp$317Kdisclosed Jul 16 · filed the same day
- ▼ SELLPaul A Mahon EVP & General CounselUTHR UNITED THERAPEUTICS Corp$63.6Kdisclosed Jul 16 · filed the same day
- ▼ SELLPaul A Mahon EVP & General CounselUTHR UNITED THERAPEUTICS Corp$558Kdisclosed Jul 16 · filed the same day
- ▼ SELLPaul A Mahon EVP & General CounselUTHR UNITED THERAPEUTICS Corp$42.9Kdisclosed Jul 16 · filed the same day
- ▼ SELLPaul A Mahon EVP & General CounselUTHR UNITED THERAPEUTICS Corp$458Kdisclosed Jul 16 · filed the same day